Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FCA eases fundraising rules to lower costs, promote growth

(Sharecast News) - The UK financial regulator has eased rules for fundraising in an effort to lower costs for companies, increase access to investment opportunities and encourage growth. In a statement on Tuesday, the Financial Conduct Authority said it was taking "bold shifts" to make it easier for UK companies to raise the money they need to grow.

These measures include doing away with (in most cases) lengthy prospectuses for listed companies to issue more shares. The FCA's new rules mean that public companies will only have to publish a prospectus when raising 75% of its existing share capital, up from the current 20% threshold, which is estimated to save UK companies £40m per share.

It is halving the amount of time needed between issuing a prospectus and an initial public offering six days to three days.

Meanwhile, the FCA will also make it easier for companies to issue corporate bonds to retail investors, and launch a new public offer platform to help smaller growth companies raise cash, which it said will work similarly to crowdfunding platforms but for larger deals.

"These bold shifts promote innovation, lower costs, and enable a broader investor base for growing businesses. They are the latest in a programme of reforms shifting the balance from pre-emptive checks to market disclosures," said Simon Walls, the executive director of markets at the FCA.

"Our capital markets are world leading. They're our economic engine, and we want to keep them roaring in support of sustained growth and prosperity for the whole country."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.